Missing Links?: 1   Citation Matrix Historiographs Glossary  HistCite Guide  About
Tue Apr 25 12:39:57 2006

Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Zhang Z, Bast RC, Yu YH, Li JN, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, van Haaften-Day C, Hacker NF, de Bruijn HWA, van der Zee AGJ, Jacobs IJ, Fung ET, Chan DW
CANCER RESEARCH 64 (16): 5882-5890 AUG 15 2004
and the citing papers

Nodes: 93, Authors: 471, Journals: 56, Outer References: 2998, Words: 376
Yearly output  |  Document Type  |  Language  |  Institution  |  Institution with Subdivision  |  Country
Collection span: 2004 - 2006
View: Overview   Sorted by year, source, volume, issue, page.

#LCRNCRNode / Date / Journal / AuthorLCSGCS
11231 2004 BMC BIOTECHNOLOGY 4: Art. No. 30
Kwapiszewska G; Meyer M; Bogumil R; Bohle RM; Seeger W; et al.
Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS
06
2192 2004 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 13 (10): 1555-1557
Semmes OJ
Defining the role of mass spectrometry in cancer diagnostics
01
30503 2004 CANCER RESEARCH 64 (16): 5882-5890
Zhang Z; Bast RC; Yu YH; Li JN; Sokoll LJ; et al.
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
9292
41374 2005 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 192 (3): 710-718
Weiner CP; Lee KY; Buhimschi CS; Christner R; Buhimschi IA
Proteomic biomarkers that predict the clinical success of rescue cerclage
04
51585 2005 AMERICAN JOURNAL OF PHARMACOGENOMICS 5 (3): 141-148
Tchabo NE; Liel MS; Kohn EC
Applying proteomics in clinical trials - Assessing the potential and practical limitations in ovarian cancer
00
61226 2005 ANALYTICAL AND BIOANALYTICAL CHEMISTRY 381 (1): 24-27
Flad T; Tolson J
Mass spectrometry meets medical sciences: making headway in molecular disease diagnostics
00
71267 2005 BIOINFORMATICS 21 (21): 4039-4045
Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SAL; Saha D; et al.
Analysis of mass spectral serum profiles for biomarker selection
00
81308 2005 BIOLOGICAL & PHARMACEUTICAL BULLETIN 28 (6): 1031-1037
Kiga C; Nakagawa T; Koizumi K; Sakurai H; Shibagaki Y; et al.
Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI ProteinChip platform
00
92409 2005 BIOMETALS 18 (6): 603-613
Zhai RH; Su SH; Lu X; Liao RQ; Ge XM; et al.
Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers
00
1013710 2005 BMC CANCER 5: Art. No. 133
Gericke B; Raila J; Sehouli J; Haebel S; Konsgen D; et al.
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
1116511 2005 BULLETIN DU CANCER 92 (9): 763-768
Solassol J; Marin P; Maudelonde T; Mange A
Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers
00
1217812 2005 BULLETIN DU CANCER 92 (10): 874-884
Eisinger F
Breast cancer screening for women with a strong familial risk
00
13110313 2005 CANCER INVESTIGATION 23 (5): 465-478
Roboz J
Mass spectrometry in diagnostic oncoproteomics
00
141114 2005 CANCER RESEARCH 65 (3): 1114-1114
Zhang Z; Chan DW
Transthyretin, a biomarker for nutritional status and ovarian cancer - In response
00
1543915 2005 CANCER RESEARCH 65 (22): 10613-10622
Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; et al.
Possible detection of pancreatic cancer by plasma protein profiling
00
1628516 2005 CLINICA CHIMICA ACTA 357 (2): 123-139
Righetti PG; Castagna A; Antonucci F; Piubelli C; Cecconi D; et al.
Proteome analysis in the clinical chemistry laboratory: Myth or reality?
01
1712917 2005 CLINICA CHIMICA ACTA 357 (2): 151-158
Colantonio DA; Chan DW
The clinical application of proteomics
22
181618 2005 CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 33 (4): 339-340
Good WV; Gendron RL
Retinopathy of prematurity: gone today, here tomorrow?
00
1912619 2005 CLINICAL CANCER RESEARCH 11 (3): 963-965
Diamandis EP; van der Merwe DE
Plasma protein profiling by mass spectrometry for cancer diagnosis: Opportunities and limitations
410
2012720 2005 CLINICAL CANCER RESEARCH 11 (22): 8042-8047
Hayashida Y; Honda K; Osaka Y; Hara T; Umaki T; et al.
Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling
01
#LCRNCRNode / Date / Journal / AuthorLCSGCS
2112221 2005 CLINICAL CANCER RESEARCH 11 (23): 8312-8320
Li JN; Zhao J; Yu XD; Lange J; Kuerer H; et al.
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid
00
2212922 2005 CLINICAL CHEMISTRY 51 (1): 1-2
Coombes KR
Analysis of mass spectrometry profiles of the serum proteome
05
2351723 2005 CLINICAL CHEMISTRY 51 (8): 1525-1528
Karsan A; Eigl BJ; Flibotte S; Gelmon K; Switzer P; et al.
Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis
15
241824 2005 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 43 (2): 125-126
White CN; Zhang Z; Chan DW
Quality control for SELDI analysis
22
2523125 2005 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 43 (12): 1281-1290
Bons JAP; Wodzig WKWH; van Dieijen-Visser MP
Protein profiling as a diagnostic tool in clinical chemistry: a review
12
2655526 2005 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 43 (12): 1314-1320
Clarke CH; Buckley JA; Fung ET
SELDI-TOF-MS proteomics of breast cancer
01
2717027 2005 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 8 (8): 669-677
Baggerman G; Vierstraete E; De Loof A; Schoofs L
Gel-based versus gel-free proteomics: A review
00
2817828 2005 DRUG DISCOVERY TODAY 10 (14): 965-976
Manne U; Srivastava RG; Srivastava S
Recent advances in biomakers for cancer diagnosis and treatment
01
29115929 2005 ELECTROPHORESIS 26 (2): 297-319
Righetti PG; Castagna A; Antonioli P; Boschetti E
Prefractionation techniques in proteome analysis: The mining tools of the third millennium
112
3034430 2005 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 5 (5): 735-743
Draghici S; Chatterjee M; Tainsky MA
Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens
01
#LCRNCRNode / Date / Journal / AuthorLCSGCS
3112331 2005 EXPERT REVIEW OF PROTEOMICS 2 (1): 139-145
Chertov O; Simpson JT; Biragyn A; Conrads TP; Veenstra TD; et al.
Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery
02
3248532 2005 EXPERT REVIEW OF PROTEOMICS 2 (3): 315-324
Nedelkov D
Population proteomic: addressing protein diversity in humans
00
33111633 2005 EXPERT REVIEW OF PROTEOMICS 2 (3): 393-406
Lathrop JT; Hayes TK; Carrick K; Hammond DJ
Rarity gives a charm: evaluation of trace proteins in plasma and serum
00
3419334 2005 FEBS JOURNAL 272 (1): 2-15
Celis JE; Moreira JMA; Gromova I; Cabezon T; Ralfkiaer U; et al.
Towards discovery-driven translational research in breast cancer
19
3513335 2005 INTERNATIONAL JOURNAL OF CANCER 115 (5): 783-789
Fung ET; Yip TT; Lomas L; Wang Z; Yip C; et al.
Classification of cancer types by measuring variants of host response proteins using SELDI serum assays
57
3613036 2005 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 15: 266-273
Boyce EA; Kohn EC
Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets
01
3715037 2005 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 15: 274-281
Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; et al.
New tumor markers: CA125 and beyond
01
3818538 2005 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 15 (5): 679-691
Duffy MJ; Bonfrer JM; Kulpa J; Rustin GJS; Soletormos G; et al.
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
00
3915139 2005 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 46 (3): 863-876
Grus FH; Podust VN; Bruns K; Lackner K; Fu SY; et al.
SELDI-TOF-MS ProteinChip Array profiling of tears from patients with dry eye
01
40311540 2005 JOURNAL OF CLINICAL ONCOLOGY 23 (20): 4524-4531
Goggins M
Molecular markers of early pancreatic cancer
04
#LCRNCRNode / Date / Journal / AuthorLCSGCS
4114641 2005 JOURNAL OF IMMUNOTHERAPY 28 (3): 183-192
Stroncek DF; Burns C; Martin BM; Rossi L; Marincola FM; et al.
Advancing cancer biotherapy with proteomics
00
4218942 2005 JOURNAL OF PROTEOME RESEARCH 4 (3): 972-981
Koomen JM; Li DH; Xiao LC; Liu TC; Coombes KR; et al.
Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery
13
4313343 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1098-1103
Srivastava S; Srivastava RG
Proteomics in the forefront of cancer biomarker discovery
01
4429244 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1143-1154
Gillette MA; Mani DR; Carr SA
Place of pattern in proteomic biomarker discovery
11
4512545 2005 JOURNAL OF PROTEOME RESEARCH 4 (5): 1672-1680
Zimmerman LJ; Wernke GR; Caprioli RM; Liebler DC
Identification of protein fragments as pattern features in MALDI-MS analyses of serum
00
4613946 2005 JOURNAL OF PROTEOME RESEARCH 4 (5): 1742-1751
Yu KH; Rustgi AK; Blair IA
Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry
00
4713647 2005 JOURNAL OF PROTEOME RESEARCH 4 (5): 1799-1804
Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; et al.
Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach
00
4812548 2005 JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 16 (8): 1221-1230
Hood BL; Lucas DA; Kim G; Chan KC; Blonder J; et al.
Quantitative analysis of the low molecular weight serum proteome using O-18 stable isotope labeling in a lung tumor xenograft mouse model
02
4912449 2005 JOURNAL OF THE NATIONAL CANCER INSTITUTE 97 (4): 310-314
Liotta LA; Lowenthal M; Mehta A; Conrads TP; Veenstra TD; et al.
Importance of communication between producers and consumers of publicly available experimental data
710
5024750 2005 JOURNAL OF THE NATIONAL CANCER INSTITUTE 97 (4): 315-319
Ransohoff DF
Lessons from controversy: Ovarian cancer screening and serum proteomics
423
#LCRNCRNode / Date / Journal / AuthorLCSGCS
5111851 2005 JOURNAL OF UROLOGY 174 (4): 1213-1217
Hara T; Honda K; Ono M; Naito K; Hirohashi S; et al.
Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry
11
5215652 2005 M S-MEDECINE SCIENCES 21 (8-9): 722-728
Solassol J; Boulle N; Maudelonde T; Mange A
Clinical proteomics: towards early detection of cancers
00
5314653 2005 MOLECULAR & CELLULAR PROTEOMICS 4 (4): 409-418
Veenstra TD; Conrads TP; Hood BL; Avellino AM; Ellenbogen RG; et al.
Biomarkers: Mining the biofluid proteome
17
5416654 2005 MOLECULAR AND CELLULAR ENDOCRINOLOGY 230 (1-2): 95-106
Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
Proteomic patterns: their potential for disease diagnosis
59
5513455 2005 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 592 (1-2): 147-154
Hayes RB; Sigurdson A; Moore L; Peters U; Huang WY; et al.
Methods for etiologic and early marker investigations in the PLCO trial
01
5613456 2005 NATURE BIOTECHNOLOGY 23 (3): 291-292
Coombes KR; Morris JRS; Hu JH; Edmonson SR; Baggerly KA
Serum proteomics profiling - a young technology begins to mature
510
5735157 2005 PHARMACOGENOMICS 6 (6): 647-653
Simpkins F; Czechowicz JA; Liotta L; Kohn EC
SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics
01
5812958 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (21): 7677-7682
Mor G; Visintin I; Lai Y; Zhao H; Schwartz P; et al.
Serum protein markers for early detection of ovarian cancer
36
5911859 2005 PROTEOMICS 5 (11): 2778-2788
Carlson SM; Najmi A; Whitin JC; Cohen HJ
Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra
00
60218260 2005 PROTEOMICS 5 (12): 3019-3034
Thadikkaran L; Siegenthaler MA; Crettaz D; Queloz PA; Schneider P; et al.
Recent advances in blood-related proteomics
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6111761 2005 PROTEOMICS 5 (13): 3343-3352
Misek DE; Kuick R; Wang H; Galchev V; Deng B; et al.
A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system
01
6213062 2005 PROTEOMICS 5 (17): 4589-4596
Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; et al.
Characterization of serum biomarkers for detection of early stage ovarian cancer
00
6313163 2005 PROTEOMICS 5 (18): 4994-5001
Sun W; Li FX; Wu SZ; Wang XR; Zheng DX; et al.
Human urine proteome analysis by three separation approaches
02
6413864 2005 RAPID COMMUNICATIONS IN MASS SPECTROMETRY 19 (12): 1624-1636
Koomen JM; Zhao HT; Li DH; Nasser W; Hawke DH; et al.
Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting
00
6522165 2005 REPRODUCTION 130 (6): 899-905
Katz-Jaffe MG; Linck DW; Schoolcraft WB; Gardner DK
A proteomic analysis of mammalian preimplantation embryonic development
00
6616866 2005 REVUE DE MEDECINE INTERNE 26 (6): 470-478
Goncalves A; Viens P; Sobol H; Maraninchi D; Bertucci F
Molecular alterations in breast cancer: clinical implications and new analytical tools
00
6714667 2005 THYROID 15 (6): 575-582
Diehl S; Umbricht CB; Dackiw APB; Zeiger MA
Modern approaches to age-old questions about thyroid tumors
00
6812568 2005 TRENDS IN PARASITOLOGY 21 (4): 154-157
Agranoff D; Stich A; Abel P; Krishna S
Proteomic fingerprinting for the diagnosis of human African trypanosomiasis
01
6925169 2006 BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY 20 (2): 321-338
Rosenthal A; Jacobs I
Familial ovarian cancer screening
00
7012570 2006 BRITISH JOURNAL OF CANCER 94 (2): 287-292
Ward DG; Cheng Y; N'Kontchou G; Thar TT; Barget N; et al.
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
7114771 2006 CANCER RESEARCH 66 (3): 1376-1383
Moscova N; Marsh DJ; Baxter RC
Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines
00
7213172 2006 CANCER RESEARCH 66 (3): 1464-1472
Werbowetski-Ogilvie TE; Agar NYR; de Oliveira RMW; Faury D; Antel JP; et al.
Isolation of a natural inhibitor of human malignant glial cell invasion: Inter alpha-trypsin inhibitor heavy chain 2
00
7342873 2006 CLINICA CHIMICA ACTA 366 (1-2): 249-256
Bons JAP; de Boer D; van Dieijen-Visser MP; Wodzig WKWH
Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry
00
7434674 2006 CLINICAL CANCER RESEARCH 12 (2): 323-327
Chambers AF; Vanderhyden BC
Ovarian cancer biomarkers in urine
00
7524875 2006 CLINICAL CANCER RESEARCH 12 (2): 432-441
Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; et al.
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine
11
763676 2006 CLINICAL CHEMISTRY 52 (4): 772-772
Li JN; Zhang Z; Chan DW
Validation of breast cancer biomarkers identified by mass spectrometry - Respond
00
7723277 2006 CURRENT OPINION IN CHEMICAL BIOLOGY 10 (1): 50-55
Geho DH; Liotta LA; Petricoin EF; Zhao WD; Araujo RP
The amplified peptidome: the new treasure chest of candidate biomarkers
00
78111778 2006 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 6 (2): 179-191
Ginsburg GS; Haga SB
Translating genomic biomarkers into clinically useful diagnostics
00
7922079 2006 FERTILITY AND STERILITY 85 (1): 101-107
Katz-Jaffe MG; Gardner DK; Schoolcraft WB
Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability
00
8011780 2006 GYNECOLOGIC ONCOLOGY 100 (2): 247-253
Kong FB; White CN; Xiao XY; Feng YJ; Xu CJ; et al.
Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
8112181 2006 INTERNATIONAL JOURNAL OF CANCER 118 (2): 412-421
Lomnytska M; Dubrovska A; Hellman U; Volodko N; Souchelnytskyi S
Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients
00
8214382 2006 INTERNATIONAL JOURNAL OF CANCER 118 (7): 1750-1758
Le Page C; Ouellet W; Madore J; Hudson TJ; Tonin PN; et al.
From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer
00
8323683 2006 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 16: 139-146
Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; et al.
Plasma proteomic pattern as biomarkers for ovarian cancer
00
84117084 2006 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 16: 152-165
Crijns APG; Duiker EW; de Jong S; Willemse PHB; van der Zee AGJ; et al.
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy
00
8532085 2006 JOURNAL OF CLINICAL INVESTIGATION 116 (1): 26-30
Liotta LA; Petricoin EF
Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold
00
8647986 2006 JOURNAL OF CLINICAL INVESTIGATION 116 (1): 271-284
Villanueva J; Shaffer DR; Philip J; Chaparro CA; Erdjument-Bromage H; et al.
Differential exoprotease activities confer tumor-specific serum peptidome patterns
24
8712487 2006 JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY 54 (1): 13-17
Ernst G; Melle C; Schimmel B; Bleul A; von Eggeling F
Proteohistography - Direct analysis of tissue with high sensitivity and high spatial resolution using ProteinChip technology
00
8814888 2006 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 147 (2): 83-90
Baker AF; Dragovich T; Tate WR; Ramanathan RK; Roe D; et al.
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma
00
8913489 2006 JOURNAL OF MOLECULAR DIAGNOSTICS 8 (1): 76-83
Steg A; Wang WQ; Blanquicett C; Grunda JM; Eltoum IA; et al.
Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array - Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma
00
9026890 2006 JOURNAL OF PROTEOME RESEARCH 5 (1): 19-25
Ebert MPA; Korc M; Malfertheiner P; Rocken C
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
9123791 2006 JOURNAL OF PROTEOME RESEARCH 5 (2): 254-261
Beyer S; Walter Y; Hellmann J; Kramer PJ; Kopp-Schneider A; et al.
Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra
00
9225092 2006 ONCOGENE 25 (7): 981-989
Goncalves A; Esterni B; Bertucci F; Sauvan R; Chabannon C; et al.
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy
00
9322793 2006 PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 33 (1): 5-9
Li F; Fang Y; Xiao ZQ; Chen ZC
Clinical proteomics: The application of proteomics in the research of clinical medicine
00

Generated by HistCite 2006.02.28